uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Antiplatelet agents for the treatment and prevention of atherothrombosis
Show others and affiliations
2011 (English)In: European Heart Journal, ISSN 0195-668X, E-ISSN 1522-9645, Vol. 32, no 23, 2922-32 p.Article, review/survey (Refereed) Published
Abstract [en]

The clinical pharmacology of antiplatelet drugs has been reviewed previously by the European Society of Cardiology (ESC) Task force and by the 8th American College of Chest Physicians (ACCP) Evidence-Based Clinical Practice Guidelines. Moreover, information on the efficacy and safety of antiplatelet drugs in the treatment and prevention of atherothrombosis is provided by collaborative meta-analyses of 287 secondary prevention trials and 6 primary prevention trials. The present document intends to provide practicing physicians with an updated instrument to guide their choice of the most suitable antiplatelet strategy for the individual patient at risk, or with different clinical manifestations, of atherothrombosis.

Place, publisher, year, edition, pages
2011. Vol. 32, no 23, 2922-32 p.
National Category
Clinical Medicine
URN: urn:nbn:se:uu:diva-165544DOI: 10.1093/eurheartj/ehr373ISI: 000297647400007PubMedID: 22019823OAI: oai:DiVA.org:uu-165544DiVA: diva2:474210
Available from: 2012-01-09 Created: 2012-01-09 Last updated: 2013-01-10Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Siegbahn, Agneta
By organisation
Clinical ChemistryUCR-Uppsala Clinical Research Center
In the same journal
European Heart Journal
Clinical Medicine

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 152 hits
ReferencesLink to record
Permanent link

Direct link